These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 15159263)

  • 21. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality.
    Ulmer H; Kelleher C; Diem G; Concin H
    J Womens Health (Larchmt); 2004; 13(1):41-53. PubMed ID: 15006277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
    Lee AJ; Wang JJ; Kifley A; Mitchell P
    Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
    J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L; Thomas F; Bean K; Benetos A; Pannier B
    Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality.
    Ho JS; Cannaday JJ; Barlow CE; Mitchell TL; Cooper KH; FitzGerald SJ
    Am J Cardiol; 2008 Sep; 102(6):689-92. PubMed ID: 18773989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA).
    Baggio B; Budakovic A; Perissinotto E; Maggi S; Cantaro S; Enzi G; Grigoletto F;
    Nephrol Dial Transplant; 2005 Jan; 20(1):114-23. PubMed ID: 15572387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals.
    Ravaglia G; Forti P; Maioli F; Bastagli L; Chiappelli M; Montesi F; Bolondi L; Patterson C
    Diabetes Care; 2006 Nov; 29(11):2471-6. PubMed ID: 17065687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.